(Q48708119)

14 February 2018

meta-analysis

0 references

title

Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis. (English)

1 reference

14 February 2018

major depressive disorder

main subject

1 reference

1 reference

1

1 reference

14 February 2018

author name string

Koke SC

series ordinal

2

1 reference

14 February 2018

Nilsson ME

series ordinal

3

1 reference

14 February 2018

Gonzales JS

series ordinal

4

1 reference

14 February 2018

publication date

1 November 2000

1 reference

14 February 2018

published in

Clinical Therapeutics

1 reference

14 February 2018

volume

22

1 reference

14 February 2018

issue

11

1 reference

14 February 2018

page(s)

1319-1330

1 reference

14 February 2018

Fluoxetine versus tricyclic antidepressants: a prospective multicenter study of antidepressant drug overdoses. The Antidepressant Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983028-3

7 January 2021

Adverse events and treatment discontinuations in fluoxetine clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983028-3

7 January 2021

A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983028-3

7 January 2021

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983028-3

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983028-3

7 January 2021

Estimation of a common effect parameter from sparse follow-up data

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983028-3

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983028-3

7 January 2021

10.1016/S0149-2918(00)83028-3

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018